May 13, 2020 — The PRECEPT study testing the use of the Biosense Webster Thermocool Smarttouch SF Catheter for the treatment of persistent atrial fibrillation (AF), resulted in freedom from any documented, symptomatic atrial arrhythmias at 15 months post-procedure for eight out of ten study participants (80.4 percent).[1] The trial was presented as a late-breaking study at the Heart Rhythm Society (HRS) 2020 Science virtual meeting.

May 13, 2020 — The patient-administered nasal spray drug etripamil did not meet its primary endpoint in treating patients with paroxysmal supraventricular tachycardia (PSVT), according to th results of the NODE-301 Trial presented as a late-breaking study at the Heart Rhythm Society (HRS) 2020 virtual meeting.

May 12, 2020 — Medtronic has received U.S. Food and Drug Administration (FDA) approval for its Cobalt and Crome implantable cardioverter-defibrillators (ICD) and cardiac resynchronization therapy-defibrillators (CRT-D),the first Medtronic “high power” devices to offer connected health, including the ability for clinicians to program devices from a physical distance,thereby reducing potential exposure to the virus that causes COVID-19.

May 12, 2020 — The U.S. Food and Drug Administration (FDA) has cleared the next-generation CardioFocus Inc. HeartLight X3 Endoscopic Ablation System for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation (PAF).

May 12, 2020 — Medis acquired Advanced Medical Imaging Development S.r.l. (AMID), a developer and supplier specialized  in cardiovascular mechanics and innovative image processing in ultrasound and other modalities. The strategic acquisition will expedite Medis' expansion in new areas of cardiovascular disease, and secure its access to key technologies to further enhance its innovative portfolio of post-processing solutions for X-ray, MRI, CT, IVUS, OCT and ultrasound devices.

May 11, 2020 — The American Society for Preventive Cardiology (ASPC) is collaborating with Intervent International to provide its members and their patients free access to Intervent's evidence-based, personalized, online/digital, educational resources and content.

May 11, 2020 – Competitive athletes are a rapidly growing population worldwide. Habitual vigorous exercise, a defining characteristic of this population, can cause various changes in cardiac structure and function known as cardiac remodeling. Clinicians treating these athletes need to be prepared as optimal use of multimodality imaging in competitive athletes requires both an understanding of exercise-induced cardiac remodeling and the strengths and weaknesses of available imaging techniques. 

May 11, 2020 — The American College of Cardiology (ACC) will begin collecting COVID-19 (SARS-CoV-2) data through the National Cardiovascular Data Registry (NCDR) Chest Pain-MI and CathPCI registries. The ACC said the goal is to capture the relationship between COVID-19 and heart disease and maximize data on the cardiac impact of the virus. 

May 8, 2020 — Final results from the UNTOUCHED study of the Emblem Subcutaneous Implantable Defibrillator (S-ICD) System were presented at Heart Rhythm Society (HRS) 2020 Science virtual meeting. 

May 8, 2020 – A new clinical study found that patients with atrial fibrillation (AF) experienced a high incidence of clinically silent brain infarcts, despite taking oral anticoagulants for stroke prevention. Silent brain infarcts were significantly associated withcognitive decline.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now